Delivery Order SPE2DB24D2003-SPE2DB25FXMF7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of OFEV 150 mg capsules (60-count units) valued at $8,590.58 with a completion date of October 10, 2025. This is a firm fixed-price, non-set-aside contract delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $8,630.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules (60-count unit) on July 21, 2025. The contract, which is expected to be completed by August 11, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of OFEV 150 mg capsules (60-count units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of October 1, 2025. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 29, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OFEV 150 mg capsules (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of OFEV 150 mg capsules (60-unit quantity). The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,630.28 for OFEV 100 mg capsules (60-count units) on August 6, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMF7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of OFEV 100 mg capsules (60-count units) valued at $8,630.28 with a firm fixed-price structure. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's broad federal contract portfolio demonstrates its capability to supply an extensive range of pharmaceutical products and medical commodities across multiple therapeutic domains. This delivery order for OFEV (pirfenidone), a specialty medication used in pulmonary fibrosis treatment, exemplifies the company's role in providing specialized therapeutic agents to support federal healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/2/25 |